Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets (Parenthetical)

v3.25.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Accumulated amortization of deferred leasing costs $ 43,253 $ 44,060
Common shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common shares of beneficial interest, shares issued (in shares) 112,882,315 112,703,460
Common shares of beneficial interest, shares outstanding (in shares) 112,882,315 112,703,460
Investing Receivables    
Investing receivable allowance for credit loss $ 3,362 $ 2,792